Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,899,030
  • Shares Outstanding, K 61,358
  • Annual Sales, $ 78,590 K
  • Annual Income, $ -146,960 K
  • 60-Month Beta 2.22
  • Price/Sales 23.30
  • Price/Cash Flow N/A
  • Price/Book 2.58
Trade KYMR with:

Options Overview Details

View History
  • Implied Volatility 82.70% ( -0.38%)
  • Historical Volatility 40.48%
  • IV Percentile 62%
  • IV Rank 34.20%
  • IV High 169.84% on 10/20/23
  • IV Low 37.42% on 07/21/23
  • Put/Call Vol Ratio 0.50
  • Today's Volume 3
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 1.20
  • Today's Open Interest 1,054
  • Open Int (30-Day) 1,765

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.69
  • Number of Estimates 12
  • High Estimate -0.41
  • Low Estimate -0.81
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -2.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.24 +3.35%
on 06/28/24
36.62 -17.48%
on 06/12/24
-1.89 (-5.89%)
since 05/31/24
3-Month
29.24 +3.35%
on 06/28/24
39.63 -23.74%
on 05/14/24
-7.42 (-19.71%)
since 04/02/24
52-Week
9.60 +214.79%
on 11/02/23
45.31 -33.30%
on 02/27/24
+7.23 (+31.45%)
since 06/30/23

Most Recent Stories

More News
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
KYMR : 30.22 (-2.36%)
RHHBY : 34.4300 (-0.61%)
GILD : 68.40 (-0.35%)
AMGN : 310.77 (-0.08%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
KYMR : 30.22 (-2.36%)
RHHBY : 34.4300 (-0.61%)
GILD : 68.40 (-0.35%)
AMGN : 310.77 (-0.08%)
Why Shares of Kymera Therapeutics Jumped on Tuesday

The company had a big bounce after hitting a 52-week low the day before.

SNY : 48.54 (-2.12%)
KYMR : 30.22 (-2.36%)
Join These Motley Fool Investors for "The Market Cap Game Show"

Multiplying the number of shares by the share price is just step one.

ASML : 1,047.89 (+1.39%)
AMZN : 200.00 (+1.42%)
MELI : 1,596.48 (-0.07%)
ETSY : 58.26 (+2.19%)
PYPL : 58.97 (+2.01%)
CELH : 57.24 (-1.04%)
KYMR : 30.22 (-2.36%)
MA : 444.65 (+1.61%)
BOC : 12.92 (-0.39%)
PCOR : 67.98 (+2.70%)
WMT : 68.07 (+0.87%)
X-Chem and Kymera Expand Existing Partnership

X-Chem , the leading provider of innovative solutions in early-stage drug discovery, today announced the expansion of its collaboration with Kymera Therapeutics, Inc. (NASDAQ: KYMR). With the expanded...

KYMR : 30.22 (-2.36%)
Delta, Kymera rise; Charter, ABM Industries fall

Stocks that traded heavily or had substantial price changes Wednesday: Delta, Kymera rise; Charter, ABM Industries fall

ABM : 50.25 (+0.18%)
VSAT : 13.74 (+9.22%)
DAL : 46.71 (-0.45%)
CHTR : 303.50 (+2.53%)
MSFT : 459.28 (+0.56%)
KYMR : 30.22 (-2.36%)
LII : 536.00 (+2.34%)
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners

Business wins are shining the spotlight on these two companies.

COMP : 3.53 (+5.06%)
$NASX : 18,028.76 (+0.84%)
KYMR : 30.22 (-2.36%)
RNA : 38.80 (-6.01%)
SNY : 48.54 (-2.12%)
Kymera Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Business Update

Initiated dosing in patient cohort (Part C) of IRAK4 degrader KT-474 Phase 1 trial, on track for data by year end Phase 1 patient studies initiated...

KYMR : 30.22 (-2.36%)
Kymera Therapeutics to Report Second Quarter 2022 Results on August 9

WATERTOWN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing...

KYMR : 30.22 (-2.36%)
Kymera Therapeutics Strengthens Board of Directors with Appointment of People and Business Leader Leigh Morgan

WATERTOWN, Mass., July 08, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing...

KYMR : 30.22 (-2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

See More

Key Turning Points

3rd Resistance Point 32.85
2nd Resistance Point 32.05
1st Resistance Point 31.13
Last Price 30.22
1st Support Level 29.41
2nd Support Level 28.61
3rd Support Level 27.69

See More

52-Week High 45.31
Fibonacci 61.8% 31.67
Last Price 30.22
Fibonacci 50% 27.46
Fibonacci 38.2% 23.24
52-Week Low 9.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar